215 related articles for article (PubMed ID: 33635151)
1. Bright spotty lesions as an imaging marker for neuromyelitis optica spectrum disorder.
Salama S; Levy M
Mult Scler; 2022 Oct; 28(11):1663-1666. PubMed ID: 33635151
[TBL] [Abstract][Full Text] [Related]
2. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
[TBL] [Abstract][Full Text] [Related]
3. The absence of antibodies in longitudinally extensive transverse myelitis may predict a more favourable prognosis.
Rocchi C; Forcadela M; Kelly P; Linaker S; Gibbons E; Bhojak M; Jacob A; Hamid S; Huda S
Mult Scler; 2024 Mar; 30(3):345-356. PubMed ID: 38258822
[TBL] [Abstract][Full Text] [Related]
4. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
[TBL] [Abstract][Full Text] [Related]
5. Frequency of Aquaporin-4 Immunoglobulin G in Longitudinally Extensive Transverse Myelitis With Antiphospholipid Antibodies.
Guerra H; Pittock SJ; Moder KG; Fryer JP; Gadoth A; Flanagan EP
Mayo Clin Proc; 2018 Sep; 93(9):1299-1304. PubMed ID: 29655487
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of bright spotty lesions on MRI after a first episode of acute myelopathy.
Rabasté S; Cobo-Calvo A; Nistiriuc-Muntean V; Vukusic S; Marignier R; Cotton F;
J Neuroradiol; 2021 Feb; 48(1):28-36. PubMed ID: 32407908
[TBL] [Abstract][Full Text] [Related]
7. MRI Features of Aquaporin-4 Antibody-Positive Longitudinally Extensive Transverse Myelitis: Insights into the Diagnosis of Neuromyelitis Optica Spectrum Disorders.
Chee CG; Park KS; Lee JW; Ahn HW; Lee E; Kang Y; Kang HS
AJNR Am J Neuroradiol; 2018 Apr; 39(4):782-787. PubMed ID: 29449281
[TBL] [Abstract][Full Text] [Related]
8. [Transverse myelitis syndrom as a result of neuromyelitis optica spectrum disorders, systemic lupus erythematosus and myasthenia gravis combination].
Topuzova MP; Bisaga GN; Alekseeva TM; Isabekova PS; Сhaykovskaya AD; Panina EB; Pavlova TA; Ternovykh IK
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(7. Vyp. 2):97-106. PubMed ID: 32844638
[TBL] [Abstract][Full Text] [Related]
9. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
[TBL] [Abstract][Full Text] [Related]
10. Clinical and radiological profile of neuromyelitis optica spectrum disorders in an Ecuadorian cohort.
Edgar Patricio CD; Eleanor THG; Francisco José CZ; Gabriela ACM; Hyland AO; Fernando GL; María TA; Beatriz N; Marcos SD; Alfredo GPW
Mult Scler Relat Disord; 2020 Sep; 44():102208. PubMed ID: 32562910
[TBL] [Abstract][Full Text] [Related]
11. Aquaporin-4-IgG positive neuromyelitis optica spectrum disorder in a paraneoplastic context.
Hyun JW; Park NY; Kim MJ; Kim H; Kim KH; Kim SH; Kim HJ
J Neurol Sci; 2023 Nov; 454():120825. PubMed ID: 37813018
[TBL] [Abstract][Full Text] [Related]
12. The frequency of longitudinally extensive transverse myelitis in MS: A population-based study.
Asnafi S; Morris PP; Sechi E; Pittock SJ; Weinshenker BG; Palace J; Messina S; Flanagan EP
Mult Scler Relat Disord; 2020 Jan; 37():101487. PubMed ID: 31707235
[TBL] [Abstract][Full Text] [Related]
13. Anti-aquaporin-1 autoantibodies in patients with neuromyelitis optica spectrum disorders.
Tzartos JS; Stergiou C; Kilidireas K; Zisimopoulou P; Thomaidis T; Tzartos SJ
PLoS One; 2013; 8(9):e74773. PubMed ID: 24086369
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging in neuromyelitis optica spectrum disorder.
Clarke L; Arnett S; Lilley K; Liao J; Bhuta S; Broadley SA
Clin Exp Immunol; 2021 Dec; 206(3):251-265. PubMed ID: 34080180
[TBL] [Abstract][Full Text] [Related]
15. Age at onset predicts outcome in aquaporin-4-IgG positive neuromyelitis optica spectrum disorder from a United Kingdom population.
Papathanasiou A; Tanasescu R; Tench CR; Rocha MF; Bose S; Constantinescu CS; Jacob S
J Neurol Sci; 2021 Dec; 431():120039. PubMed ID: 34715481
[TBL] [Abstract][Full Text] [Related]
16. Longitudinally extensive transverse myelitis immune-mediated in aquaporin-4 antibody negative patients: Disease heterogeneity.
Carnero Contentti E; Hryb JP; Morales S; Gomez A; Chiganer E; Di Pace JL; Lessa C; Perassolo M
J Neurol Sci; 2017 Feb; 373():134-137. PubMed ID: 28131170
[TBL] [Abstract][Full Text] [Related]
17. Centrally-located transverse myelitis would facilitate the differentiation of NMOSD and MOG-AD from MS.
Etemadifar M; Salari M; Etemadifar MR; Sabeti F; Fateh ST; Aminzade Z
Mult Scler Relat Disord; 2022 Apr; 60():103664. PubMed ID: 35219242
[TBL] [Abstract][Full Text] [Related]
18. Short segment myelitis as the initial and only manifestation of aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorders.
Fang W; Zheng Y; Yang F; Cai MT; Shen CH; Liu ZR; Zhang YX; Ding MP
Ther Adv Neurol Disord; 2020; 13():1756286419898594. PubMed ID: 32010226
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes and predictive factors related to good outcomes in plasma exchange in severe attack of NMOSD and long extensive transverse myelitis: Case series and review of the literature.
Aungsumart S; Apiwattanakul M
Mult Scler Relat Disord; 2017 Apr; 13():93-97. PubMed ID: 28427710
[TBL] [Abstract][Full Text] [Related]
20. Clinical and paraclinical profile of neuromyelitis optic spectrum disorder in a peruvian cohort.
Castro-Suarez S; Guevara-Silva E; Osorio-Marcatinco V; Alvarez-Toledo K; Meza-Vega M; Caparó-Zamalloa C
Mult Scler Relat Disord; 2022 Aug; 64():103919. PubMed ID: 35691236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
